title: Commentary regarding: A randomized trial of icatibant in ACE-inhibitor-induced angioedema.
authors.affiliation: Department of Dermatology, University of Texas Southwestern Medical Center in Dallas, Dallas, Texas.
authors.forename: Kim B
authors.initials: KB
authors.lastname: Yancey
mesh_terms: D000799:Angioedema / Q000188:drug therapy*; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000009:adverse effects*; D001920:Bradykinin / Q000031:analogs & derivatives*; D065094:Bradykinin B2 Receptor Antagonists / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008297:Male
chemical_list: D000806:Angiotensin-Converting Enzyme Inhibitors; D065094:Bradykinin B2 Receptor Antagonists; D001920:Bradykinin
keywords: ACE-inhibitor; angioedema; bradykinin; drug reaction